# VELCADE
> **NDA021602** · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2003-05-13
## Drug
- **FDA Application Number:** NDA021602
- **Application type:** New Drug Application
- **Brand name:** VELCADE
- **Generic name:** BORTEZOMIB
- **Active ingredients:** BORTEZOMIB
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** TAKEDA PHARMS USA
- **Manufacturer:** Takeda Pharmaceuticals America, Inc.
- **First approval:** 2003-05-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021602)
---
*AI Analytics · CC0 1.0*